BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 28794631)

  • 1. Surface-enhanced Raman spectroscopy of serum accurately detects prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL.
    Chen N; Rong M; Shao X; Zhang H; Liu S; Dong B; Xue W; Wang T; Li T; Pan J
    Int J Nanomedicine; 2017; 12():5399-5407. PubMed ID: 28794631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification analyses for prostate cancer, benign prostate hyperplasia and healthy subjects by SERS-based immunoassay of multiple tumour markers.
    Zhou L; Liu Y; Wang F; Jia Z; Zhou J; Jiang T; Petti L; Chen Y; Xiong Q; Wang X
    Talanta; 2018 Oct; 188():238-244. PubMed ID: 30029370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining SERS analysis of serum with PSA levels for improving the detection of prostate cancer.
    Stefancu A; Moisoiu V; Couti R; Andras I; Rahota R; Crisan D; Pavel IE; Socaciu C; Leopold N; Crisan N
    Nanomedicine (Lond); 2018 Oct; 13(19):2455-2467. PubMed ID: 30284481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface-enhanced Raman spectroscopy of urine for prostate cancer detection: a preliminary study.
    Del Mistro G; Cervo S; Mansutti E; Spizzo R; Colombatti A; Belmonte P; Zucconelli R; Steffan A; Sergo V; Bonifacio A
    Anal Bioanal Chem; 2015 May; 407(12):3271-5. PubMed ID: 25791298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of expressed prostatic secretion and serum using surface-enhanced Raman spectroscopy for the noninvasive detection of prostate cancer, a preliminary study.
    Shao X; Pan J; Wang Y; Zhu Y; Xu F; Shangguan X; Dong B; Sha J; Chen N; Chen Z; Wang T; Liu S; Xue W
    Nanomedicine; 2017 Apr; 13(3):1051-1059. PubMed ID: 27979746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-enhanced Raman spectroscopy of preoperative serum samples predicts Gleason grade group upgrade in biopsy Gleason grade group 1 prostate cancer.
    Qian H; Shao X; Zhu Y; Fan L; Zhang H; Dong B; Wang Y; Xu F; Zhen W; Kang X; Chen N; Liu S; Pan J; Xue W
    Urol Oncol; 2020 Jun; 38(6):601.e1-601.e9. PubMed ID: 32241690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface-enhanced Raman spectroscopy before radical prostatectomy predicts biochemical recurrence better than CAPRA-S.
    Pan J; Shao X; Zhu Y; Dong B; Wang Y; Kang X; Chen N; Chen Z; Liu S; Xue W
    Int J Nanomedicine; 2019; 14():431-440. PubMed ID: 30666105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface-enhanced Raman spectroscopy of blood serum based on gold nanoparticles for the diagnosis of the oral squamous cell carcinoma.
    Tan Y; Yan B; Xue L; Li Y; Luo X; Ji P
    Lipids Health Dis; 2017 Apr; 16(1):73. PubMed ID: 28388900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of prostate cancer by Raman spectroscopy: A multivariate study on patients with normal and altered PSA values.
    Correia NA; Batista LTA; Nascimento RJM; Cangussú MCT; Crugeira PJL; Soares LGP; Silveira L; Pinheiro ALB
    J Photochem Photobiol B; 2020 Mar; 204():111801. PubMed ID: 31978674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME
    Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
    Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Label-free serum detection of Trichinella spiralis using surface-enhanced Raman spectroscopy combined with multivariate analysis.
    Li J; Ding J; Liu X; Tang B; Bai X; Wang Y; Li S; Wang X
    Acta Trop; 2020 Mar; 203():105314. PubMed ID: 31866336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a high throughput (HT) Raman spectroscopy method for rapid screening of liquid blood plasma from prostate cancer patients.
    Medipally DK; Maguire A; Bryant J; Armstrong J; Dunne M; Finn M; Lyng FM; Meade AD
    Analyst; 2017 Apr; 142(8):1216-1226. PubMed ID: 28001146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood plasma surface-enhanced Raman spectroscopy for non-invasive optical detection of cervical cancer.
    Feng S; Lin D; Lin J; Li B; Huang Z; Chen G; Zhang W; Wang L; Pan J; Chen R; Zeng H
    Analyst; 2013 Jul; 138(14):3967-74. PubMed ID: 23529624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer detection based on serum sample surface enhanced Raman spectroscopy.
    Vargas-Obieta E; Martínez-Espinosa JC; Martínez-Zerega BE; Jave-Suárez LF; Aguilar-Lemarroy A; González-Solís JL
    Lasers Med Sci; 2016 Sep; 31(7):1317-24. PubMed ID: 27289243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on gastric cancer blood plasma based on surface-enhanced Raman spectroscopy combined with multivariate analysis.
    Feng S; Pan J; Wu Y; Lin D; Chen Y; Xi G; Lin J; Chen R
    Sci China Life Sci; 2011 Sep; 54(9):828-34. PubMed ID: 21809036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate cut-off point for free to total prostate-specific antigen ratio used to improve differentiation of prostate cancer from benign prostate hyperplasia in Iranian population.
    Amirrasouli H; Kazerouni F; Sanadizade M; Sanadizade J; Kamalian N; Jalali M; Rahbar K; Karimi K
    Urol J; 2010 Jun; 7(2):99-104. PubMed ID: 20535696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer detection by gold nanoparticle based surface-enhanced Raman spectroscopy of blood serum and statistical analysis.
    Lin D; Feng S; Pan J; Chen Y; Lin J; Chen G; Xie S; Zeng H; Chen R
    Opt Express; 2011 Jul; 19(14):13565-77. PubMed ID: 21747512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
    Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
    Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of prostate-specific antigen testing in patients with prostate disease.
    Yu HJ; Chie WC; Hsieh CH; Tsai CC; Lai MK
    J Formos Med Assoc; 1996 Oct; 95(10):782-8. PubMed ID: 8961676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.